Lourdes Cortes‐Dericks
About
In The Last Decade
Lourdes Cortes‐Dericks
17 papers receiving 595 citations
Peers
Comparison fields: 5 of 66
- Oncology 212
- Molecular Biology 192
- Surgery 121
- Pulmonary and Respiratory Medicine 117
- Genetics 110
Countries citing papers authored by Lourdes Cortes‐Dericks
This map shows the geographic impact of Lourdes Cortes‐Dericks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lourdes Cortes‐Dericks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lourdes Cortes‐Dericks more than expected).
Fields of papers citing papers by Lourdes Cortes‐Dericks
This network shows the impact of papers produced by Lourdes Cortes‐Dericks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lourdes Cortes‐Dericks. The network helps show where Lourdes Cortes‐Dericks may publish in the future.
Co-authorship network of co-authors of Lourdes Cortes‐Dericks
This figure shows the co-authorship network connecting the top 25 collaborators of Lourdes Cortes‐Dericks. A scholar is included among the top collaborators of Lourdes Cortes‐Dericks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lourdes Cortes‐Dericks. Lourdes Cortes‐Dericks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 15 | |
| 3 | 30 | |
| 4 | 22 | |
| 5 | 36 | |
| 6 | 1 | |
| 7 | 26 | |
| 8 | 70 | |
| 9 | 90 | |
| 10 | Suppression of OCT4B enhances sensitivity of lung adenocarcinoma A549 cells to cisplatin via increased apoptosis. | 14 |
| 11 | 30 | |
| 12 | 24 | |
| 13 | 35 | |
| 14 | 16 | |
| 15 | 35 | |
| 16 | 100 | |
| 17 | 47 | |
| 18 | 12 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.